Scienture (NASDAQ:SCNX) Stock Price Down 6.6% – Here’s What Happened

Posted by Sarita Garza on Jul 23rd, 2026

Scienture Holdings, Inc. (NASDAQ:SCNX – Get Free Report)’s stock price fell 6.6% on Tuesday . The company traded as low as $0.3750 and last traded at $0.3886. 316,716 shares changed hands during mid-day trading, a decline of 92% from the average daily volume of 3,902,358 shares. The stock had previously closed at $0.4160.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Scienture in a research note on Wednesday, June 24th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $1.50.

Check Out Our Latest Stock Report on SCNX

Scienture Trading Down 2.3%

The company’s 50 day moving average price is $0.38 and its two-hundred day moving average price is $0.41. The stock has a market cap of $15.89 million, a P/E ratio of -0.16 and a beta of 3.28.

Scienture (NASDAQ:SCNX – Get Free Report) last announced its earnings results on Friday, May 15th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.15. The business had revenue of $0.06 million for the quarter, compared to the consensus estimate of $0.40 million.

Institutional Investors Weigh In On Scienture

A hedge fund recently bought a new position in Scienture stock. Virtu Financial LLC acquired a new position in Scienture Holdings, Inc. (NASDAQ:SCNX – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 89,930 shares of the company’s stock, valued at approximately $46,000. Virtu Financial LLC owned approximately 0.22% of Scienture at the end of the most recent reporting period. 5.68% of the stock is currently owned by hedge funds and other institutional investors.

Scienture Company Profile

(Get Free Report)

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.